EMD Serono Revenue and Competitors
Estimated Revenue & Valuation
- EMD Serono's estimated annual revenue is currently $571.1M per year.
- EMD Serono's estimated revenue per employee is $248,000
- EMD Serono's total funding is $137.3M.
Employee Data
- EMD Serono has 2303 Employees.
- EMD Serono grew their employee count by -4% last year.
EMD Serono's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Staff, Office the Chief Marketing Officer | Reveal Email/Phone |
2 | Head North America Medical Governance | Reveal Email/Phone |
3 | Head Global Learning for Merck KGaA, Darmstadt, Germany | Reveal Email/Phone |
4 | VP, MS Franchise Marketing | Reveal Email/Phone |
5 | Head RPO Management, Americas | Reveal Email/Phone |
6 | Head Regional Subsidiaries Quality North America | Reveal Email/Phone |
7 | Head, Operational Design Center, Clinical Operations & Program Design | Reveal Email/Phone |
8 | Head Data Driven Innovation & Analytics | Reveal Email/Phone |
9 | Head Channel/Trade Distribution & Customer Operations - Market Access & Patient Solutions | Reveal Email/Phone |
10 | VP, Head Data Sciences | Reveal Email/Phone |
EMD Serono Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is EMD Serono?
Serono is a global biotechnology leader and a developer of recombinant prescription medicines. We offer the world's fastest growing multiple sclerosis therapy and are the world leader in infertility treatment. We offer the only growth hormone approved for the treatment of HIV-associated wasting and the only needle-free growth hormone delivery system, available with both our pediatric growth and HIV-associated wasting therapies. By combining cutting-edge science with unparalleled patient support, we have emerged as a leader in using biotechnology to improve human lives.
keywords:N/A
$137.3M
Total Funding
2303
Number of Employees
$571.1M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
EMD Serono News
Merck & Co. F. Hoffmann-La Roche AG. Johnson & Johnson. Novartis International AG. AbbVie inc. Pfizer inc. Sanofi S.A. inc. yte. EMD Serono...
"Through EMD Serono's Embracing Carers Initiative, we are striving to identify and raise awareness of these critical findings for the caregiver...
ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, the Healthcare business sector of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today...